Artelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challenge tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Roflumilast improves atopic dermatitis symptoms in children aged 2 to 5 years healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Artelo Biosciences (ARTL) Picked as a Finalist in Johnson & Johnson's (JNJ) Innovation Challenge streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
After stage 4 melanoma diagnosis, treatment, William Shatner shares new outlook on life healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
New data show that JNJ-2113, the first and only investigational oral targeted peptide, maintained skin clearance in moderate-to-severe plaque psoriasis for one year.The FRONTIER 2 long-term extension.